An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

Basit Öğe Kaydı
dc.authorid0000-0001-9636-4113
dc.contributor.authorSevindik, Ömür Gökmen
dc.contributor.authorÖzkurt, Zübeyde Nur
dc.contributor.authorBoğa, Can
dc.contributor.authorKalayoğlu Beşışık, Sevgi
dc.contributor.authorİpek, Yıldız
dc.contributor.authorGedük, Ayfer
dc.contributor.authorHarmandalı, Aybüke
dc.contributor.authorSalihoğlu, Ayşe
dc.contributor.authorHaydaroğlu Şahin, Handan
dc.contributor.authorSönmez, Mehmet
dc.contributor.authorVural, Filiz
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorKurt Yüksel, Meltem
dc.contributor.authorMaral, Senem
dc.contributor.authorEkinci, Ömer
dc.contributor.authorKırkızlar, Hakkı Onur
dc.contributor.authorTekinalp, Atakan
dc.contributor.authorDemir, Nazlı
dc.contributor.authorMerter, Mustafa
dc.contributor.authorSaydam, Güray
dc.contributor.authorAlacacıoğlu, İnci
dc.contributor.authorYeğin, Zeynep Arzu
dc.contributor.authorKasar, Mutlu
dc.contributor.authorMastanzade, Metban
dc.contributor.authorÖzsan, Güner Hayri
dc.date.accessioned2021-12-06T11:35:18Z
dc.date.available2021-12-06T11:35:18Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground To investigate the demographics and treatment details of the myeloma patients who were diagnosed and followed up in Turkey and received up to two lines of therapy. Methods Patients who were recorded on the database of Turkish Myeloma Registry project were included in this study if they had only received one or two lines of therapy. Demographics, patient, and disease related parameters both at the time of diagnosis and at the follow up and treatment outcomes were presented.
dc.identifier.citationSevindik, Ö. G., Özkurt, Z. N., Boğa, C., Kalayoğlu Beşışık, S., İpek, Y., Gedük, A. ... Özsan, G. H. (2021). An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy. Clinical Lymphoma, Myeloma & Leukemia içinde (S102-S103. ss.).
dc.identifier.endpageS103
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.issueSupplement:2
dc.identifier.startpageS102
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8618
dc.identifier.volume21
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCIG Media Group
dc.relation.ispartofClinical Lymphoma, Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectTurkish Myeloma Registry
dc.subjectLines of Therapy
dc.subjectInterim Analysis
dc.titleAn interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Sevindik-Omur-2021.pdf
Boyut:
140.2 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu